Thermo Fisher Scientific Inc (TMO) dropped slightly amid mild profit booking and the last known price was $151.98 per share. The price decreased by -0.41 points or -0.27% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $16.57 million. The total upticks were valued at $119.77 million and the total downticks aggregated to $103.2 million, thereby putting the up/down ratio at 1.16,. The shares has seen a change in the share price of 4.49% on a weekly basis.In a big block trade which occurred today, the total uptick value was $28.87 million and the total downtick value was $10.23, resulting in an up/down ratio of 2.82. The net money flow for the block trade was calculated to be $18.64 million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of Thermo Fisher Scientific Inc. rose by 7.38% in the last five trading days and 8.39% for the last 4 weeks. Thermo Fisher Scientific Inc. is up 4.13% in the last 3-month period. Year-to-Date the stock performance stands at 8.39%. Thermo Fisher Scientific Inc (NYSE:TMO) rose 0.36% or 0.55 points on Wednesday and made its way into the gainers of the day. After trading began at $152.27 the stock was seen hitting $155.1 as a peak level and $151.48 as the lowest level. The stock ended up at $152.94. The daily volume was measured at 3,601,963 shares. The 52-week high of the share price is $160.675 and the 52-week low is $119.75. The company has a market cap of $60,415 million.
Company has reported several Insider transactions to the SEC, on Sep 6, 2016, Marc N Casper (Chief Executive Officer) sold 28,797 shares at 151.01 per share price.On Aug 31, 2016, Daniel P Shine (Senior Vice President) sold 1,699 shares at 152.28 per share price.On Aug 31, 2016, Thomas W Loewald (Senior Vice President) sold 3,256 shares at 152.28 per share price.
Thermo Fisher Scientific Last issued its quarterly earnings results on Jan 31, 2017. The company reported $2.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.03. Analyst had a consensus of $2.38. The company had revenue of $4953.20 million for the quarter, compared to analysts expectations of $4989.01 million. The companys revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.12 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Thermo Fisher Scientific was Initiated by Deutsche Bank on Jan 18, 2017 to Buy, Price Target of the shares are set at $163.Thermo Fisher Scientific was Resumed by Leerink Partners to Outperform on Nov 10, 2016.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Companys four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.